Perrigo (PRGO) Gains from Investment Securities (2012 - 2014)
Perrigo (PRGO) posted quarterly Gains from Investment Securities of $12.7 million for Q1 2014, up 693.75% year-over-year from $1.6 million in Q1 2013, and up 693.75% quarter-over-quarter from $1.6 million in Q1 2013.
Perrigo (PRGO) Gains from Investment Securities (2012 - 2014) Analysis & Trends
Perrigo (PRGO) has reported Gains from Investment Securities for 3 consecutive years, with $12.7 million the latest figure, recorded in Q1 2014.
- In Q1 2014, Gains from Investment Securities rose 693.75% year-over-year to $12.7 million; the TTM figure through Jun 2014 stood at $12.7 million (changed N/A YoY), while the FY2014 annual figure was $12.7 million, up 170.21% from the prior year.
- Gains from Investment Securities improved to $12.7 million in Q1 2014 per PRGO's latest filing, from $1.6 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $12.7 million in Q1 2014 and bottomed at $1.6 million in Q1 2013.
- Historically, Gains from Investment Securities has averaged $5.8 million across 3 years, with a median of $3.0 million in 2012.
- On a YoY basis, Gains from Investment Securities climbed as much as 693.75% in 2014 and fell as far as 693.75% in 2014.
- Perrigo's Gains from Investment Securities stood at $3.0 million in 2012, then tumbled by 46.67% to $1.6 million in 2013, then surged by 693.75% to $12.7 million in 2014.
- Business Quant data shows PRGO's Gains from Investment Securities at $12.7 million in Q1 2014, $1.6 million in Q1 2013, and $3.0 million in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2014 | 12.70 Mn |
| Mar 29, 2014 | 12.70 Mn |
| Mar 30, 2013 | 1.60 Mn |
| Mar 30, 2013 | 1.60 Mn |
| Dec 29, 2012 | 3.00 Mn |
| Dec 29, 2012 | 3.00 Mn |